Publications by authors named "Davide Quarta"

Claim this Profile
T
Three predictive scores compared in a retrospective multicenter study of nonunion tibial shaft fracture.
Davide Quarta, Marco Grassi, Giuliano Lattanzi, Antonio Pompilio Gigante, Alessio D'Anca

World J Orthop· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rewarding, reinforcing and incentive salient events involve orexigenic hypothalamic neuropeptides regulating mesolimbic dopaminergic neurotransmission.
Davide Quarta, Ilse Smolders

Eur J Pharm Sci· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serotonin antagonists in the five-choice serial reaction time task and their interactions with nicotine.
Davide Quarta, Christopher G Naylor, Jeffrey C Glennon, Ian P Stolerman

Behav Pharmacol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of lamotrigine on PCP-evoked elevations in monoamine levels in the medial prefrontal cortex of freely moving rats.
Davide Quarta, Charles H Large

J Psychopharmacol· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reinforcing and neurochemical effects of cannabinoid CB1 receptor agonists, but not cocaine, are altered by an adenosine A2A receptor antagonist.
Zuzana Justinová, Sergi Ferré, Godfrey H Redhi, Paola Mascia, Jessica Stroik, Davide Quarta

Addict Biol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The GABA-B positive modulator GS39783 decreases psychostimulant conditioned-reinforcement and conditioned-reward.
Briac Halbout, Davide Quarta, Enzo Valerio, Christian A Heidbreder, Daniel M Hutcheson

Addict Biol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy of sodium channel blockers to prevent phencyclidine-induced cognitive dysfunction in the rat: potential for novel treatments for schizophrenia.
Charles H Large, Silvia Bison, Ilaria Sartori, Kevin D Read, Alessandro Gozzi, Davide Quarta

J Pharmacol Exp Ther· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Orexin-1 receptor antagonist SB-334867 reduces the acquisition and expression of cocaine-conditioned reinforcement and the expression of amphetamine-conditioned reward.
Daniel M Hutcheson, Davide Quarta, Briac Halbout, Aurélie Rigal, Enzo Valerio

Behav Pharmacol· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased phasic activity of VTA dopamine neurons in mice 3 weeks after repeated social defeat.
Maria Razzoli, Michela Andreoli, Francesca Michielin, Davide Quarta, David M Sokal

Behav Brain Res· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The orexin-1 receptor antagonist SB-334867 reduces amphetamine-evoked dopamine outflow in the shell of the nucleus accumbens and decreases the expression of amphetamine sensitization.
Davide Quarta, Enzo Valerio, Daniel M Hutcheson, Gael Hedou, Christian Heidbreder

Neurochem Int· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug discrimination and neurochemical studies in alpha7 null mutant mice: tests for the role of nicotinic alpha7 receptors in dopamine release.
Davide Quarta, Christopher G Naylor, Jacques Barik, Cathy Fernandes, Susan Wonnacott

Psychopharmacology (Berl)· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic administration of ghrelin increases extracellular dopamine in the shell but not the core subdivision of the nucleus accumbens.
Davide Quarta, Carla Di Francesco, Sergio Melotto, Laura Mangiarini, Christian Heidbreder

Neurochem Int· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adenosine A1-A2A receptor heteromers: new targets for caffeine in the brain.
Sergi Ferre, Francisco Ciruela, Janusz Borycz, Marcello Solinas, Davide Quarta

Front Biosci· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Different effects of ionotropic and metabotropic glutamate receptor antagonists on attention and the attentional properties of nicotine.
Davide Quarta, Christopher G Naylor, Hannah V Morris, Swital Patel, Rachel F Genn

Neuropharmacology· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The serotonin 2C receptor agonist Ro-60-0175 attenuates effects of nicotine in the five-choice serial reaction time task and in drug discrimination.
Davide Quarta, Christopher G Naylor, Ian P Stolerman

Psychopharmacology (Berl)· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heteromeric nicotinic acetylcholine-dopamine autoreceptor complexes modulate striatal dopamine release.
Davide Quarta, Francisco Ciruela, Kshitij Patkar, Janusz Borycz, Marcello Solinas

Neuropsychopharmacology· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Involvement of adenosine A1 receptors in the discriminative-stimulus effects of caffeine in rats.
Marcello Solinas, Sergi Ferré, Katerina Antoniou, Davide Quarta, Zuzana Justinova

Psychopharmacology (Berl)· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adenosine receptor-mediated modulation of dopamine release in the nucleus accumbens depends on glutamate neurotransmission and N-methyl-D-aspartate receptor stimulation.
Davide Quarta, Janusz Borycz, Marcello Solinas, Kshitij Patkar, Jörg Hockemeyer

J Neurochem· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opposite modulatory roles for adenosine A1 and A2A receptors on glutamate and dopamine release in the shell of the nucleus accumbens. Effects of chronic caffeine exposure.
Davide Quarta, Sergi Ferré, Marcello Solinas, Zhi-Bing You, Jörg Hockemeyer

J Neurochem· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Involvement of adenosine A1 and A2A receptors in the motor effects of caffeine after its acute and chronic administration.
Marzena Karcz-Kubicha, Katerina Antoniou, Anton Terasmaa, Davide Quarta, Marcello Solinas

Neuropsychopharmacology· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enabling role of adenosine A1 receptors in adenosine A2A receptor-mediated striatal expression of c-fos.
Marzena Karcz-Kubicha, Davide Quarta, Bruce T Hope, Katerina Antoniou, Christa E Müller

Eur J Neurosci· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blockade of striatal adenosine A2A receptor reduces, through a presynaptic mechanism, quinolinic acid-induced excitotoxicity: possible relevance to neuroprotective interventions in neurodegenerative diseases of the striatum.
Patrizia Popoli, Annita Pintor, Maria Rosaria Domenici, Claudio Frank, Maria Teresa Tebano, Davide Quarta

J Neurosci· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis